Navigation Links
Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval)
Date:9/25/2008

nd Direct Relief International ("DRI") have formed an alliance whereby Napo will provide CRO-PED at cost for distribution through DRI's network. Initially, the program is expected to reach 1.1 million children per year in sub-Saharan Africa who lack access to clean water. Ultimately, it is anticipated that an estimated 38 million people per year, including caregivers and the families of those children with diarrheal diseases, may be positively affected through this partnership. Napo is seeking additional NGO partners for similar programs.

"Napo is committed to a business model that not only reaches the lucrative Western markets, but will also allow us to serve global populations in need. The investment we are seeking as part of the CGI pledge would have a return based on those Western market sales," commented Lisa Conte, CEO of Napo Pharmaceuticals. "Due to the excellent safety profile of crofelemer in all clinical trials and its positive antidiarrhoeal activity, we believe crofelemer, once approved, can help save lives and improve the health of millions of children in resource constrained areas around the world ."

In addition to the CAP, Napo's CGI commitment also includes the sustainable harvesting of Croton lechleri, the raw material source of crofelemer, from rain forest areas of South America. The agroforestry will provide income to more than 5000 individuals upon the approval of crofelemer across the range of its intended indications, helping to conserve valuable forest land. Napo is committed to adhering to fair trade practices in sourcing the raw material from the suppliers in rain forest areas.

Crofelemer is currently in final Phase 3 clinical development for chronic diarrhea in people living with HIV/AIDS in adults in the US (CRO-HIV), and has been tested for safety in children as young as three months of age. The approval of CRO-PED by the FDA is subject to the prior approval of an adult formulation of crofelemer. The Company plans to
'/>"/>

SOURCE Napo Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
2. DFB Sells Coria Labs to Valeant Pharmaceuticals
3. Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008
4. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
5. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
6. Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
7. Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
8. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
9. VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16
10. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009
11. Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014  Next month, executives from clinical trial marketing ... events beginning with Patient-Centered Clinical Trials 2014 , to ... Boston , September 4-5. Patient recruitment experts Bonnie ... Fleishman will share insights on the benefits of employing ... tactics – from media to mobile apps – can be ...
(Date:8/28/2014)... Aug. 28, 2014  Armetheon, Inc. ( www.armetheon.com ... mid- to late-stage cardiovascular drug candidates, today announced ... first round of financing. The Series A round ... Bioventures with participation from investors that included Atheneos ... Dr. Larry Hsu , the founder of ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 A ... around the world is available from Strategic Consulting, ... companies. “ Industrial Microbiology Market Review, Fourth Edition: ... Market ” (IMMR—4) tracks and compares microbiology test ... North America, Europe and Asia, and forecasts future ...
(Date:8/28/2014)... Supplementing their complete line of ... Eppendorf Safe Lock Centrifuge Tubes . This ... quality tubes at an affordable price. Eppendorf Safe ... chemical, medical, pharmaceutical, and life science research and ... able to afford Eppendorf products. , Eppendorf is ...
Breaking Biology Technology:BBK Worldwide Leads Sessions at Key September Events 2Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3
... 1 A new technology known as,ActivePure ... proven in peer-reviewed, published university laboratory studies ... inoculated,surfaces. Recent outbreaks of MRSA in ... parents concerned. Based on NASA research, ...
... Nov. 1 Martek Biosciences,Corporation (Nasdaq: MATK ... United,States District Court in Wilmington, Delaware, has ruled ... injunction in Martek,s favor,against the defendants in the ... Nutrinova Inc. and Nutrinova Nutrition Specialties &,Food Ingredients ...
... ON, Nov. 1 /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: VSGN ; ... following investor conferences in November: Acumen BioFin Rodman ... New York Palace Hotel Tuesday, November 6, 2007 ... Conference, Four Seasons Hotel, Boston Tuesday, November 13, ...
Cached Biology Technology:New ActivePure Technology Proven To Reduce Exposure to Methicillin Resistant Staphylococcus Aureus (MRSA) 2Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge 2Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge 3Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences 2Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences 3
(Date:8/27/2014)... is related to ability that we already possess. For ... more easily than learning how to hit a tennis ... Neural Basis of Cognition (CNBC)a joint program between the ... fundamental constraint in the brain that may explain why ... Aug. 28, 2014, issue of Nature , they ...
(Date:8/27/2014)... Athens, Ga. An invasive grass species frequently found ... spiders, who then feed on American toads, a new ... which was accidentally introduced to the U.S. in the ... species and has spread to more than a dozen ... Typically found along roads and in forests, it can ...
(Date:8/27/2014)... When we want to listen carefully to someone, the ... thing we do is stop moving altogether. This strategy ... by our own movements. , This interplay between movement ... brain. Indeed, indirect evidence has long suggested that the ... auditory cortex, which gives rise to our conscious perception ...
Breaking Biology News(10 mins):Pitt and Carnegie Mellon engineers discover why learning can be difficult 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 3More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3
... environmental enrichment and increased social stress can both affect ... monkey research at Wake Forest University School of Medicine., ... that social rank whether animals are dominant or ... amount of cocaine that monkeys will self-administer. Housed in ...
... Institute (HHMI) researchers have found that rare mutations in ... general population. , The scientists had previously shown that ... rare diseases that are characterized by low blood pressure. ... are participating in the Framingham Heart Study, the researchers ...
... Recent research at Yale provided a glimpse of ... illuminated a relationship between gene processing in humans and ... structure of a crucial self-splicing region of RNA. ... through intermediary RNA molecules. But, after transcription from the ...
Cached Biology News:Environmental enrichment can reduce cocaine use, researchers find 2Rare genetic mutations protect against hypertension 2Rare genetic mutations protect against hypertension 3Rare genetic mutations protect against hypertension 4Yale scientists visualize the machinery of mRNA splicing 2
{3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide}. ,250 ug/ml Propidium Iodide (PI) in PBS....
Propidium Iodide: {3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diodide}. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 2.5ug/mL Propidium Iodide (PI)...
Detects caspase activation by flow cytometry....
Concentration: 1mg/ml. Antigen: Propidium Iodide ...
Biology Products: